- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma
Total 12246 results
-
National Cancer Institute (NCI)TerminatedMonoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaUnited States
-
PETHEMA FoundationRecruitingMultiple Myeloma in RelapseSpain
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, France, Poland, Australia, Netherlands, United Kingdom, India
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
Rennes University HospitalIntergroupe Francophone du MyelomeTerminatedMonoclonal Gammopathy of Undetermined Significance | Smoldering MyelomaFrance
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia
-
University of UtahRecruitingSmoldering Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Hellenic Society of HematologyJanssen PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaGreece
-
National Cancer Institute (NCI)TerminatedMultiple Myeloma | Smoldering Multiple Myeloma | MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMonoclonal Gammopathy of Undetermined Significance | Smoldering Plasma Cell MyelomaUnited States
-
University Hospital, MontpellierPoitiers University HospitalUnknownPatients With Recurrent or Refractory Multiple MyelomaFrance
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedMultiple Myeloma Bone DiseaseUnited Kingdom, United States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLeukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non-hodgkin's LymphomaChina
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Medical Research CouncilUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited Kingdom
-
Seoul St. Mary's HospitalActive, not recruitingMyeloma MultipleKorea, Republic of
-
Regeneron PharmaceuticalsNot yet recruitingMonoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)
-
Oxford University Hospitals NHS TrustAmgenCompletedMyeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)United Kingdom
-
Centro de Atencion e Investigacion MedicaNot yet recruiting
-
M.D. Anderson Cancer CenterRecruiting
-
LifeTime PharmaceuticalsUnknownMultiple Myeloma and Plasma Cell Neoplasm | Precancerous ConditionUnited States
-
Shanxi Bethune HospitalRecruiting
-
Shahid Beheshti University of Medical SciencesNot yet recruitingMultiple Myeloma, RefractoryIran, Islamic Republic of
-
Shenzhen Geno-Immune Medical InstituteThe Second Affiliated Hospital of Hainan Medical UniversityRecruiting
-
University of PennsylvaniaGenentech, Inc.Recruiting
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
University Hopsital Schleswig Holstein Campus LübeckRecruitingNewly Diagnosed Multiple MyelomaGermany
-
Sheba Medical CenterRecruitingMultiple Myeloma | Relapse Multiple MyelomaIsrael
-
Chunrui LiNanjing IASO Biotherapeutics Co.,LtdRecruitingExtramedullary Multiple MyelomaChina
-
Xinqiao Hospital of ChongqingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingMultiple Myeloma, RefractoryChina
-
University of Colorado, DenverNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMultiple Myeloma in RelapseUnited States
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States
-
Karyopharm Therapeutics IncRecruiting
-
Turkish Hematology AssociationRecruitingMultiple Myeloma | Relapse Multiple MyelomaTurkey
-
Oslo University HospitalRecruiting
-
Travera IncMassachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaboratorsRecruitingMultiple Myeloma in RelapseUnited States
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
NexImmune Inc.SuspendedRelapsed Refractory Multiple MyelomaUnited States
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
EMN Research ItalyActive, not recruitingRelapsed Multiple MyelomaItaly
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.; Celgene CorporationActive, not recruitingMultiple Myeloma in RelapseUnited States
-
OncotherapeuticsTakedaTerminatedNewly Diagnosed Multiple MyelomaUnited States
-
AbbVieCompletedMultiple Myeloma (MM)United States, Argentina, Australia, Brazil, Canada, Croatia, Czechia, France, Germany, Greece, Ireland, Israel, Italy, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovenia, Spain, Taiwan, Turkey
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
GWT-TUD GmbHActive, not recruitingRefractory Multiple MyelomaGermany